Found: 101
Select item for more details and to access through your institution.
Efficacy of brain radiotherapy plus EGFR-TKI for EGFR-mutated non-small cell lung cancer patients who develop brain metastasis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Treatment and prognosis after progression in long-term responders to EGFR-tyrosine kinase inhibitor in advanced non-small cell lung cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Molecular Profiling and Survival of Completely Resected Primary Pulmonary Neuroendocrine Carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
MET Gene Amplification and Overexpression in Chinese Non-Small-Cell Lung Cancer Patients Without EGFR Mutations.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
First-in-human, phase 1 dose-escalation and dose-expansion study of a RET inhibitor SY-5007 in patients with advanced RET-altered solid tumors.
- Published in:
- Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02006-9
- By:
- Publication type:
- Article
Efficacy of rechallenge immunotherapy after immune monotherapy resistance in patients with advanced non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 20, p. 17987, doi. 10.1007/s00432-023-05490-8
- By:
- Publication type:
- Article
Pretherapy investigations using highly robust visualized biomarkers from CT imaging by multiple machine-learning techniques toward its prognosis prediction for ALK-inhibitor therapy in NSCLC: a feasibility study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7341, doi. 10.1007/s00432-023-04615-3
- By:
- Publication type:
- Article
Adjuvant therapy in stage II thymic carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 2, p. 349, doi. 10.1007/s00432-013-1562-6
- By:
- Publication type:
- Article
Cutaneous metastasis as a initial presentation in advanced non-small cell lung cancer and its poor survival prognosis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 10, p. 1613, doi. 10.1007/s00432-012-1239-6
- By:
- Publication type:
- Article
EGFR L861Q mutation is a frequent feature of pulmonary mucoepidermoid carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 8, p. 1421, doi. 10.1007/s00432-012-1211-5
- By:
- Publication type:
- Article
Proton pump inhibitors enhance macropinocytosis‐mediated extracellular vesicle endocytosis by inducing membrane v‐ATPase assembly.
- Published in:
- Journal of Extracellular Vesicles, 2024, v. 13, n. 4, p. 1, doi. 10.1002/jev2.12426
- By:
- Publication type:
- Article
Extracellular vesicles: Natural liver‐accumulating drug delivery vehicles for the treatment of liver diseases.
- Published in:
- Journal of Extracellular Vesicles, 2020, v. 10, n. 2, p. 1, doi. 10.1002/jev2.12030
- By:
- Publication type:
- Article
Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-β degradation.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31141-6
- By:
- Publication type:
- Article
Efficacy of gefitinib or erlotinib in patients with squamous cell lung cancer.
- Published in:
- Archives of Medical Science, 2015, v. 11, n. 1, p. 164, doi. 10.5114/aoms.2013.39234
- By:
- Publication type:
- Article
Comparison of the efficacy and safety of anlotinib monotherapy or anlotinib plus immune checkpoint inhibitor for advanced small cell lung cancer with brain metastases.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 7, p. 1687, doi. 10.1007/s12094-024-03390-y
- By:
- Publication type:
- Article
Joint Serum Tumor Markers Serve as survival predictive model of Erlotinib in the treatment of recurrent Non-small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2014, v. 17, n. 5, p. 391, doi. 10.3779/j.issn.1009-3419.2014.05.05
- By:
- Publication type:
- Article
Relationship Between BIM Gene Polymorphism and Therapeutic Efficacy in the Retreatment of Advanced Non-small Cell Lung Cancer with Tyrosine Kinase Inhibitor.
- Published in:
- Chinese Journal of Lung Cancer, 2013, v. 16, n. 12, p. 632, doi. 10.3779/j.issn.1009-3419.2013.12.03
- By:
- Publication type:
- Article
Efficacy of Icotinib for Advanced Non-small Cell Lung Cancer Patients with EGFR Status Identified.
- Published in:
- Chinese Journal of Lung Cancer, 2013, v. 16, n. 3, p. 138, doi. 10.3779/j.issn.1009-3419.2013.03.04
- By:
- Publication type:
- Article
Retrospective Study on Lobe-specific Lymph Node Dissection for Patients with Early-stage Non-small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2012, v. 15, n. 9, p. 531, doi. 10.3779/j.issn.1009-3419.2012.09.05
- By:
- Publication type:
- Article
Advances of Molecular Subtype and Targeted Therapy of Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2012, v. 15, n. 9, p. 545, doi. 10.3779/j.issn.1009-3419.2012.09.07
- By:
- Publication type:
- Article
Analysis of the Efficacy and Survival of Third-line Treatment in Advanced Non-small Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2012, v. 15, n. 6, p. 369, doi. 10.3779/j.issn.1009-3419.2012.06.08
- By:
- Publication type:
- Article
Safety Analysis of Ambulatory Chemotherapy in Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2010, v. 13, n. 7, p. 713, doi. 10.3779/j.issn.1009-3419.2010.07.10
- By:
- Publication type:
- Article
Assessment of efficacy and safety of MET tyrosine kinase inhibitors in non-small-cell lung cancer patients with MET alterations.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241248352
- By:
- Publication type:
- Article
Poor efficacy of immune checkpoint inhibitor treatment in advanced thymic carcinoma patients with liver metastases.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241253127
- By:
- Publication type:
- Article
Clinical characteristics and prognostic impact of immune checkpoint inhibitor-associated myocarditis in advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 6, p. 816, doi. 10.1007/s10637-023-01400-4
- By:
- Publication type:
- Article
Treatment outcomes and prognosis of patients with primary and acquired BRAF‐mutated non‐small cell lung cancer: A multicenter retrospective study.
- Published in:
- Genes, Chromosomes & Cancer, 2022, v. 61, n. 9, p. 530, doi. 10.1002/gcc.23043
- By:
- Publication type:
- Article
Association Between RET Fusions and Efficacy of Pemetrexed-based Chemotherapy for Patients With Advanced NSCLC in China: A Multicenter Retrospective Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
De Novo MET Amplification in Chinese Patients With Non-Small-Cell Lung Cancer and Treatment Efficacy With Crizotinib: A Multicenter Retrospective Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39139-4
- By:
- Publication type:
- Article
The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia.
- Published in:
- Contrast Media & Molecular Imaging, 2022, p. 1, doi. 10.1155/2022/2256690
- By:
- Publication type:
- Article
Targeting KRAS mutant cancers: from druggable therapy to drug resistance.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01629-2
- By:
- Publication type:
- Article
Targeting KRAS mutant cancers: from druggable therapy to drug resistance.
- Published in:
- Molecular Cancer, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12943-022-01629-2
- By:
- Publication type:
- Article
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1693, doi. 10.1007/s00262-021-03115-y
- By:
- Publication type:
- Article
Fas signaling-mediated T<sub>H</sub>9 cell differentiation favors bowel inflammation and antitumor functions.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10889-4
- By:
- Publication type:
- Article
Primary tracheobronchial mucoepidermoid carcinoma - a retrospective study of 32 patients.
- Published in:
- World Journal of Surgical Oncology, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1477-7819-11-62
- By:
- Publication type:
- Article
Analysis of the tumor length and other prognosis factors in pT1-2 node-negative esophageal squamous cell carcinoma in a Chinese population.
- Published in:
- World Journal of Surgical Oncology, 2012, v. 10, n. 1, p. 273, doi. 10.1186/1477-7819-10-273
- By:
- Publication type:
- Article
Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial.
- Published in:
- BMC Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12916-022-02361-w
- By:
- Publication type:
- Article
Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Development and validation of prognostic nomogram for T<sub>1-3</sub>N<sub>0</sub>M<sub>0</sub> non-small cell lung cancer after curative resection.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11158-w
- By:
- Publication type:
- Article
Effects of intrapericardial administration after catheter drainage on malignant pericardial effusion in non‐small cell lung cancer: A real‐world study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 17, p. 18211, doi. 10.1002/cam4.6404
- By:
- Publication type:
- Article
The combination of etoposide and platinum for the treatment of thymic neuroendocrine neoplasms: A retrospective analysis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 15, p. 16011, doi. 10.1002/cam4.6245
- By:
- Publication type:
- Article
Comparison of efficacy and safety of second‐ and third‐generation TKIs for non‐small‐cell lung cancer with uncommon EGFR mutations.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 15, p. 15903, doi. 10.1002/cam4.6229
- By:
- Publication type:
- Article
The effect of EGFR‐TKIs on survival in advanced non‐small‐cell lung cancer with EGFR mutations: A real‐world study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 5, p. 5630, doi. 10.1002/cam4.5413
- By:
- Publication type:
- Article
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 5, p. 5649, doi. 10.1002/cam4.5357
- By:
- Publication type:
- Article
A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 154, doi. 10.1002/cam4.978
- By:
- Publication type:
- Article
Mutation and prognostic analyses of PIK3 CA in patients with completely resected lung adenocarcinoma.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 10, p. 2694, doi. 10.1002/cam4.852
- By:
- Publication type:
- Article
Patients with ROS1 rearrangement-positive non-small-cell lung cancer benefit from pemetrexed-based chemotherapy.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 10, p. 2688, doi. 10.1002/cam4.809
- By:
- Publication type:
- Article
Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.657283
- By:
- Publication type:
- Article
Exploration of efficacy of different therapy regimens for advanced NSCLC patients with KRAS mutation in the first-line treatment.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 10, p. 2479, doi. 10.1007/s12094-024-03485-6
- By:
- Publication type:
- Article